British Journal of Medical & Surgical Urology
Volume 2, Issue 2 , Pages 67-72 , March 2009

Improving bladder cancer outcomes: The impact of initiating a phase IV randomised controlled clinical trial

Received 26 October 2008 ,Accepted 9 November 2008.

References 

  1. Wright J, Whelan TJ, Schiff S, Dubois S, Crooks D, Haines PT, et al. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol. 2004;22:4312–4318
  2. Vist GE, Hagen KB, Devereaux PJ, Bryant D, Oxman AD. Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev. 2007;
  3. National patient safety agency: doing less harm. Department of Health.
  4. ISRCTN 14275387. 2-9-2005. Ref Type: Internet Communication.
  5. Singh R, Saleemi A, Walsh K, Popert R, O’Brien T. Near misses in bladder cancer—an airline safety approach to urology. Ann R Coll Surg Engl. 2003;85:378–381
  6. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou J. EAU: Guidelines on T1Ta (non-muscle invasive) bladder cancer, Chapter 1; 2008 edition.
  7. Hsueh Y. The Hawthorne experiments and the introduction of Jean Piaget in American industrial psychology, 1929–1932. Hist Psychol. 2002;5:163–189
  8. Mayo E. The human problems of an industrial civilization. New York: MacMillan; 1933;Chapter 3
  9. Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41:523–531

PII: S1875-9742(08)00124-9

doi: 10.1016/j.bjmsu.2008.11.006

British Journal of Medical & Surgical Urology
Volume 2, Issue 2 , Pages 67-72 , March 2009

Article Tools